ASP Isotopes is trading 5.3% up today at $4.09 after announcing a research agreement between its subsidiary, Quantum Leap Energy, and the Texas A&M Engineering Experiment Station to advance high-purity uranium hexafluoride (UF6) conversion technology.
- The collaboration focuses on developing processes for the production of High-Assay Low-Enriched Uranium (HALEU), a critical fuel for next-generation nuclear reactors.
- Investors are reacting positively to the company’s expanded U.S. nuclear fuel R&D footprint, which strengthens its long-term uranium conversion and enrichment ambitions.